South Africa Covid-19 Vaccine

Novavax and Serum Institute of India (SII) announced a regulatory submission to the South African Health Products Regulatory Agency for emergency use authorization (EUA) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine

A two-dose course of Pfizer Inc. and BioNTech SE's Covid-19 shot as well as a previous infection with the disease may give stronger protection against the omicron variant, scientists from the Africa Health Research Institute in South Africa said.

Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70 per cent protection against hospitalisation in South Africa in recent weeks, according to a major real-world study which suggests weaker efficacy against the new Omicron variant.

Less than half of the African continent is amenable to mandatory vaccinations for COVID-19, according to a study by a group of scientists, which was published in the peer-reviewed journal, PLOS One.

Pfizer Inc.'s vaccine provides less immunity to the omicron variant than to other major versions of Covid-19, according to laboratory experiments that still indicated a third dose may help stop the highly mutated strain.

A new variant of Covid-19 detected in South Africa known as B.1.1.529 has caused flight bans and a scramble to determine vaccine efficacy.

The EU's drug regulator said on Friday that it was closely monitoring the new B.1.1.529 Covid-19 variant, but it was too soon to tell if updated vaccines would be needed.

Britain said on Friday that a newly identified coronavirus variant spreading in South Africa was considered by scientists to be the most significant one yet found and so it needed to ascertain whether or not it made vaccines ineffective.

Namibia has discontinued the use of Russia's Sputnik V Covid-19 vaccine following concerns raised by neighbouring South Africa, the health ministry said on Saturday.

South Africa's health products regulator on Monday said it would not approve Russia's Sputnik V Covid-19 vaccine due to concerns it could increase the risk of HIV infection among men.

South Africa's President Cyril Ramaphosa on Sunday announced plans to introduce COVID-19 "vaccine passports" amid widespread scepticism of the jab, ahead of an easing of movement restrictions this week.

South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.

A new variant of S-CoV-2, the virus which cause COVID-19, has been detected in South Africa and many other countries globally which could be more transmissible and evade protection provided by vaccines, according to study.

Covid vaccine makers BioNTech and Pfizer said Wednesday they would produce their jab in South Africa from 2022, a first for the continent that could see much-needed immunisation drives pick up speed.

South Africa announced Friday it would start vaccinating people under 50 years old as the continent's hardest-hit country buckles under a vicious third wave of COVID-19 infections driven by the Delta variant.

Novavax and Serum Institute of India (SII) announced a regulatory submission to the South African Health Products Regulatory Agency for emergency use authorization (EUA) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine

A two-dose course of Pfizer Inc. and BioNTech SE's Covid-19 shot as well as a previous infection with the disease may give stronger protection against the omicron variant, scientists from the Africa Health Research Institute in South Africa said.

Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70 per cent protection against hospitalisation in South Africa in recent weeks, according to a major real-world study which suggests weaker efficacy against the new Omicron variant.

Less than half of the African continent is amenable to mandatory vaccinations for COVID-19, according to a study by a group of scientists, which was published in the peer-reviewed journal, PLOS One.

Pfizer Inc.'s vaccine provides less immunity to the omicron variant than to other major versions of Covid-19, according to laboratory experiments that still indicated a third dose may help stop the highly mutated strain.

A new variant of Covid-19 detected in South Africa known as B.1.1.529 has caused flight bans and a scramble to determine vaccine efficacy.

The EU's drug regulator said on Friday that it was closely monitoring the new B.1.1.529 Covid-19 variant, but it was too soon to tell if updated vaccines would be needed.

Britain said on Friday that a newly identified coronavirus variant spreading in South Africa was considered by scientists to be the most significant one yet found and so it needed to ascertain whether or not it made vaccines ineffective.

Namibia has discontinued the use of Russia's Sputnik V Covid-19 vaccine following concerns raised by neighbouring South Africa, the health ministry said on Saturday.

South Africa's health products regulator on Monday said it would not approve Russia's Sputnik V Covid-19 vaccine due to concerns it could increase the risk of HIV infection among men.

South Africa's President Cyril Ramaphosa on Sunday announced plans to introduce COVID-19 "vaccine passports" amid widespread scepticism of the jab, ahead of an easing of movement restrictions this week.

South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.

A new variant of S-CoV-2, the virus which cause COVID-19, has been detected in South Africa and many other countries globally which could be more transmissible and evade protection provided by vaccines, according to study.

Covid vaccine makers BioNTech and Pfizer said Wednesday they would produce their jab in South Africa from 2022, a first for the continent that could see much-needed immunisation drives pick up speed.

South Africa announced Friday it would start vaccinating people under 50 years old as the continent's hardest-hit country buckles under a vicious third wave of COVID-19 infections driven by the Delta variant.